Resources from the same session
Welcome, introduction, and goal setting
Presenter: Stephen Johnston
Session: PeerView Oncology - supported by Lilly - Safeguarding patients with HR+, HER2-, high-risk, early breast cancer: A practical roadmap for CDK4/6 inhibition in the adjuvant setting
Resources:
Webcast
Conducting risk assessment in HR+, HER2- EBC to identify patients at high risk of recurrence
Presenter: Joyce O'Shaughnessy
Session: PeerView Oncology - supported by Lilly - Safeguarding patients with HR+, HER2-, high-risk, early breast cancer: A practical roadmap for CDK4/6 inhibition in the adjuvant setting
Resources:
Webcast
Mitigating adverse events, improving adherence/persistence, and maximizing treatment benefits from CDK4/6 inhibitors in high-risk, HR+, HER2- EBC
Presenter: Patrick Neven
Session: PeerView Oncology - supported by Lilly - Safeguarding patients with HR+, HER2-, high-risk, early breast cancer: A practical roadmap for CDK4/6 inhibition in the adjuvant setting
Resources:
Webcast
Q&A, synthesis, and conclusions
Session: PeerView Oncology - supported by Lilly - Safeguarding patients with HR+, HER2-, high-risk, early breast cancer: A practical roadmap for CDK4/6 inhibition in the adjuvant setting
Resources:
Webcast